Clinical Trials Logo

Bioavailability clinical trials

View clinical trials related to Bioavailability.

Filter by:

NCT ID: NCT04097808 Completed - Bioavailability Clinical Trials

Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects

Start date: September 20, 2019
Phase: N/A
Study type: Interventional

The aim of this study is the comparison of the oral bioavailability of hydroxyproline, a key marker for collagen peptide intake, after ingestion of collagen peptides from different sources, sizes and together with different food matrices, either containing high or low levels of polyphenols.

NCT ID: NCT04028739 Completed - Bioavailability Clinical Trials

Theracurmin vs Curcumin Bioavailability Study

Start date: July 31, 2019
Phase: N/A
Study type: Interventional

A randomized, open-label, cross-over, single administration study to compare bioavailability of curcumin in health adults

NCT ID: NCT03915626 Completed - Bioavailability Clinical Trials

Effect of Heat on Rivastigmine TDS Products

Start date: October 4, 2019
Phase: Early Phase 1
Study type: Interventional

This research study is designed to measure the amount of medicine in blood over time after the patch is placed on the skin with and without external heat application.

NCT ID: NCT03905564 Withdrawn - Bioavailability Clinical Trials

A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

Start date: June 2019
Phase: Phase 1
Study type: Interventional

The purpose of the study is to investigate any difference in the extent and rate of absorption of doxylamine between the test (investigational medicinal product [IMP]) and reference products that could impact the bioavailability of the medication when administered under fasting conditions.

NCT ID: NCT03794843 Recruiting - Safety Issues Clinical Trials

Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers

Start date: August 23, 2018
Phase: Early Phase 1
Study type: Interventional

A Randomized, Open-label, Single Dose, Two Formulation, Two Period, Double Cross Over Bioavailability Comparison Study of two types of Nimodipine Injections in Healthy Volunteers.

NCT ID: NCT03485885 Completed - Bioavailability Clinical Trials

Bioavailability of Maqui Berry Extract (MBE) in Healthy Subjects

Start date: November 23, 2017
Phase:
Study type: Observational

The aim of the present study is to describe the bioavailability for the proprietary standardized maqui berry extracts Delphinol® and MaquiBright® enriched in anthocyanins and in particular delphinidins. The analyses are based on two selected key substances namely delphinidin-3-glucoside and cyanidin-3-sambubioside and their metabolism to phenolic acids. The bioavailability of anthocyanins specific for Delphinol®/MaquiBright® was analyzed in plasma sample kinetics (at 0h, 0.5h, 1h, 1.5h, 2h, 3h, 4h, 6h and 8h after intake of 1000mg standardized maqui berry extract in capsules) in 12 healthy subjects.

NCT ID: NCT03443076 Completed - Bioavailability Clinical Trials

Bioavailability of EPA + DHA in a SMEDS Formulation

Start date: February 16, 2018
Phase: N/A
Study type: Interventional

This study will assess the relative bioavailability of 500 mg eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) in a self-micro-emulsifying delivery system (SMEDS) formulation compared with a standard omega-3-acid ethyl ester product in healthy men and women.

NCT ID: NCT03323593 Completed - Dexmedetomidine Clinical Trials

Pharmacokinetics of Different Mode Administration of Intranasal Dexmedetomidine

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Intranasal dexmedetomidine has been studied and used in children for premedication before anaesthesia or fro sedation. It can be administered by simple dripping or by Mucosal Atomization Device (MAD®). Since MAD® delivers intranasal medication in a fine mist, it is possible that absorption and bioavailability would be better compares to simple dripping method. To date no pharmacokinetic information of intranasal dexmedetomidine delivered by either method is available. This investigation is designed to compare the bioavailablity of intranasal dexmedetomidine deliver via simple dipping with tuberculine syringe and MAD® in healthy adults.

NCT ID: NCT03218631 Completed - Bioavailability Clinical Trials

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

Start date: July 10, 2017
Phase: Phase 1
Study type: Interventional

To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.

NCT ID: NCT03156712 Completed - Iron-deficiency Clinical Trials

Iron Absorption From Iron-enriched Aspergillus Oryzae

BIEFS
Start date: May 29, 2013
Phase: N/A
Study type: Interventional

Ferrous sulfate is rapidly absorbed and the bolus of iron enters blood rather quickly possibly leading to higher concentrations of non-transferrin bound iron which induces oxidative stress. The objective of this study was to determine how quickly iron enters into blood stream from the iron-enriched Asperigillus oryzae (AspironTM, ASP) in contrast to ferrous sulfate. Seventeen healthy, female subjects (18-35 y) were randomized, double blind, cross-over experimental design with three treatments: 10 mg iron as FeSO4 and ASP as well as 20 mg iron as ASP.